On Wednesday, Antares Pharma Inc (NASDAQ:ATRS)’s shares declined -6.96% to $2.14.
Antares Pharma Inc (ATRS) declared that it has priced a firm commitment underwritten public offering of 20,000,000 shares of the Company’s common stock at a purchase price to the public of $2.00 per share, resulting in net proceeds to the Company of $37.6 million (before estimated offering expenses payable by the Company). Piper Jaffray & Co. is acting as the sole book-running manager for the offering. Raymond James & Associates, Inc. and Oppenheimer & Co. Inc. are acting as the co-managers of the offering. The offering is predictable to close on or about May 11, 2015, subject to customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock.
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide.
Vitamin Shoppe Inc (NYSE:VSI)’s shares dropped -7.54% to $39.12.
Vitamin Shoppe Inc (VSI) declared preliminary results for the three months ended March 28, 2015. Total net sales in the first quarter raised 9.4% to $336.8 million contrast to $307.8 million in the same period of the preceding year. Stated fully-diluted earnings per share in first quarter 2015 were $0.63, contrast with $0.67 in first quarter 2014.
Vitamin Shoppe, Inc., through its auxiliaries, operates as a multi-channel specialty retailer and contract manufacturer of nutritional products in the United States. The company operates through three segments: Retail, Direct, and Manufacturing.
At the end of Wednesday’s trade, xG Technology Inc (NASDAQ:XGTI)‘s shares dipped -6.05% to $0.357.
xG Technology Inc (XGTI) declared a Planned Technology Alliance Agreement with Drakontas, LLC (“Drakontas”) to cooperate in the marketing of each other’s respective solutions. Under the terms of the agreement, xG and Drakontas will make accessible integrated products that comprise xMax private mobile broadband network technology and Drakontas’ DragonForce mobile team partnership software application.
xG Technology, Inc. develops communications technologies for wireless networks worldwide. The company’s intellectual property is embedded in proprietary software algorithms designed to offer cognitive interference mitigation and spectrum access solutions to organizations in a various industries, counting national defense and rural broadband.
IAMGOLD Corp (USA) (NYSE:IAG), ended its Wednesday’s trading session with -6.58% loss, and closed at $2.13.
IAMGOLD Corp (USA) (IAG) reports its financial and operating results for the first quarter ended March 31, 2015.
First Quarter 2015 Highlights:
- Attributable gold production and gold sales of 208,000 ozs.
- All-in sustaining costs1– gold mines2 of $1,113/oz.
- Total cash costs1,3– gold mines of $846/oz.
- Cash, cash equivalents and gold bullion (at market value) of $889.1 million at March 31, 2015 contrast to $321.0 million at December 31, 2014.
- Net cash from operating activities of $30.0 million.
IAMGOLD Corporation primarily engages in the exploration, development, and operation of gold mining properties. It also explores for silver and copper deposits. The company holds interests in four operating gold mines, in addition to exploration and development projects located in Africa, South America, and Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.